AORT News and Press, Artivion Inc. From 04/22/24

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results PR Newswire ATLANTA , April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference PR Newswire ATLANTA , April 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will pa...

2024-03-30 18:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference PR Newswire ATLANTA , March 6, 2024 /PRNewswire/ -- Artiv...

2024-02-29 00:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-15 20:22:13 ET Artivion, Inc. (AORT) Q4 2023 Earnings Conference Call February 15, 2024, 4:30 pm ET Company Participants Laine Morgan - IR, Gilmartin Group Pat Mackin - CEO Lance Berry - CFO Conference Call Participants John McAulay - Stifel ...

2024-02-15 16:17:41 ET More on Artivion Artivion Stock: A First Assessment Artivion appoints Lance A. Berry as EVP, CFO; reaffirms FY23 outlook Seeking Alpha’s Quant Rating on Artivion Historical earnings data for Artivion Financial information...

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire Fourth Quarter and Recent Business Highlights: Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18...

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...